Venetoclax combined with HMA or LDAC for relapsed/refractory AML - real-world experience from two German academic centers K. Braitsch, L. K. Schmalbrock, P. Jung, I Bumeder, P. Kiewe,J. Westermann, L. Bullinger,U. Keller,F. Bassermann,J. Kroenke, K. S. Goetze, K. RiegerONCOLOGY RESEARCH AND TREATMENT（2021）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
